A carregar...
Guillain Barré Syndrome in a multiple myeloma patient after the first course of bortezomib therapy: A case report
Bortezomib is approved for treating relapsed multiple myeloma (MM) and mantle cell lymphoma, and clinical evidence has shown complete clinical responses in MM patients. Peripheral neuropathy is one of the most common adverse effects of bortezomib. However, rare evidence has shown that bortezomib is...
Na minha lista:
| Publicado no: | Oncol Lett |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4665331/ https://ncbi.nlm.nih.gov/pubmed/26722290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.3634 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|